Home > Drug Search >
  • company_query: aRigen Pharmaceutical
  •   > 
Drug Filter
Category:
chemistry (33) biology (8)
Status:
Approved (3) NDA Filing (1) Phase Ⅲ (4) Phase Ⅱ (19) Phase Ⅰ (13) IND Filing (1)
Clinical Stage:
Pending (9) Active (25) Discontinued (4)
Bio-Type:
Recombinant enzyme (1) Bispecific antibody (1) Whole antibody (2) Fab fragment (1) ADC (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (2) Acute myeloid Leukemia (AML) (2) Alzheimer's disease (AD) (1) Asthma (3) Atopic dermatitis (1) Bladder cancer (1) Breast cancer (1) Chronic obstructive pulmonary disease (COPD) (1) Chronic pain (1) Crohn's disease (1) Diarrhea (1) Endometrial cancer (1) Gastric cancer (1) HCV infection (4) Hepatocellular carcinoma (HCC) (2) HIV infection (2) Impetigo (1) Lymphoma (1) Medullary thyroid cancer (MTC) (1) Multiple sclerosis (MS) (1) Neuropathic pain (3) Non small cell lung cancer (NSCLC) (3) Osteoarthritis (OA) (1) Ovarian cancer (2) Peptic ulcer (1) Prostate cancer (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (1) Small cell lung cancer (SCLC) (1) Solid tumours (8) Stable plaque psoriasis (1) Type 2 diabetes (1) Ulcerative colitis (1) Head and neck cancer (1) Oesophageal varices (1) Pain (3) Methicillin-resistant staphylococcus aureus infections (1) Malignant glioma (1) Cervical carcinoma (1) Acute myocardial infarction (AMI) (1) Acromegaly (1) Glioma (1) Neuroendocrine tumors (NET) (1) Plaque psoriasis (1) Liver cancer (2) Inflammation (1) Inflammatory pain (1) Blood coagulation disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top